Rock Springs Capital Management LP - ACELRX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Rock Springs Capital Management LP ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$1,323,000
-14.4%
6,329,2020.0%0.03%
-24.4%
Q2 2022$1,546,000
-14.4%
6,329,2020.0%0.04%0.0%
Q1 2022$1,807,000
-49.0%
6,329,202
+0.1%
0.04%
-45.1%
Q4 2021$3,544,000
-9.0%
6,325,902
+65.6%
0.08%0.0%
Q3 2021$3,896,000
-25.5%
3,819,402
+0.8%
0.08%
-20.4%
Q2 2021$5,228,000
-18.8%
3,788,757
+0.1%
0.10%
-26.4%
Q1 2021$6,435,000
+37.2%
3,785,457
+0.1%
0.14%
+41.4%
Q4 2020$4,690,000
-12.5%
3,782,457
+0.2%
0.10%
-27.2%
Q3 2020$5,358,0003,773,5850.14%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Monashee Investment Management LLC 1,652,190$3,817,0002.58%
LINCOLN CAPITAL CORP 62,000$143,0000.13%
Laurion Capital Management LP 1,944,727$4,492,0000.08%
Cedar Wealth Management, LLC 46,395$107,0000.08%
Fosun International Ltd 301,708$709,0000.04%
BCWM, LLC 35,100$811,0000.04%
Engineers Gate Manager LP 170,800$395,0000.03%
Alpine Global Management, LLC 45,211$104,0000.03%
MOORE CAPITAL MANAGEMENT, LP 250,000$578,0000.02%
SECTORAL ASSET MANAGEMENT INC 73,778$170,0000.02%
View complete list of ACELRX PHARMACEUTICALS INC shareholders